Repositioning of the global epicentre of non-optimal cholesterol

High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.</p

Repositioning of the global epicentre of non-optimal cholesterol

High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol�which is a marker of cardiovascular risk�changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95 credible interval 3.7 million�4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world. © 2020, The Author(s), under exclusive licence to Springer Nature Limited

Can greater understanding of macadamia canopy architecture lay the foundation for orchard productivity improvements?

Macadamia canopies tend to grow large and complex due to vigorous recurrent flushes of vegetative growth. New shoot growth can occur at any time of the year from apical and axillary buds, elongating existing axes and forming new axis orders, respectively. The macadamia canopy is relatively unmodified and low yielding, thus yield efficiency and management practices would benefit from an increased understanding of canopy growth dynamics and architecture. Here we detail a range of investigations into the architectural development of macadamia over different scales, and methods for modifying architecture with a view to this information being incorporated into the design of improved orchard systems. For isolated shoots we have documented the elongation of internodes and the whole growth unit (GU), and their relationship to thermal time. We have also undertaken a detailed architectural study on two cultivars of young trees leading up to their first flowering, in an attempt to compare and understand patterns of early vegetative development. At the tree scale there were no differences in canopy volume or tree height between cultivars, however, detailed scales revealed differences in canopy components such as GU number, GU length and branching patterns. Shoot bending can modify vegetative architecture and reproductive development in temperate crops, although responses in subtropical crops could be more complicated. Bending first-order shoots in macadamia reduced apical growth and induced axillary release. When shoots are bent at the time of floral initiation raceme number was increased on the first-order shoot axis, possibly due to a coincidence between bending-induced axillary bud release and time-dependent floral signals. Observing interactions between components at different scales aids understanding of the mechanisms and relationships controlling the structure and function of the growing macadamia canopy, thus providing opportunities to modify macadamia growth for the benefit of production efficiency

Autoimmunity in the brain: The pathogenesis insight from cell biology

The aim of the study is to explore the relationship between leakage of the blood-brain barrier and inflammation, the reason why demyelination occurs - seemingly in the absence of an antigen-specific immune response that requires explanation if a coherent account of an inflammatory-mediated demyelination is to be achieved. In this study the cellular biology of the glial cells important for the synthesis and maintenance of central nervous system (CNS) myelin and their inter-relations with other environmental cells (neuronal, microglial, olygodendroglial, astrocytes, endothelial, epithelial, T lymphocytes, B lymphocytes, monocytes, and macrophages) and with the compound of the extracellular matrix (ECM) during the development of an autoimmune inflammatory and demyelinating processes in the brain was analyzed. Upon activation in the peripheral tissue, immune cells reach their target organ via bloodstream and interacting with blood vessels wall components in the absence of exogenous stimulus mount an attack against the local milleu, which is the starting point of a pathogenic inflammatory reaction. Each of these contacts may trigger profuse secretion of cytokines, chemokines, and other soluble inflammatory mediators, which in the CNS by activating of local glial cells and by attracting and stimulating blood-borne monocyte/macrophages can act directly on neural cells and will cause their demyelination

Primordial Rotating Disk Composed of ≥\geq15 Dense Star-Forming Clumps at Cosmic Dawn

International audienceEarly galaxy formation, initiated by the dark matter and gas assembly, evolves through frequent mergers and feedback processes into dynamically hot, chaotic structures. In contrast, dynamically cold, smooth rotating disks have been observed in massive evolved galaxies merely 1.4 billion years after the Big Bang, suggesting rapid morphological and dynamical evolution in the early Universe. Probing this evolution mechanism necessitates studies of young galaxies, yet efforts have been hindered by observational limitations in both sensitivity and spatial resolution. Here we report high-resolution observations of a strongly lensed and quintuply imaged, low-luminosity, young galaxy at $z=6.072$ (dubbed the Cosmic Grapes), 930 million years after the Big Bang. Magnified by gravitational lensing, the galaxy is resolved into at least 15 individual star-forming clumps with effective radii of $r_{\rm e}\simeq$ 10--60 parsec (pc), which dominate $\simeq$ 70% of the galaxy's total flux. The cool gas emission unveils a smooth, underlying rotating disk characterized by a high rotational-to-random motion ratio and a gravitationally unstable state (Toomre $Q \simeq$ 0.2--0.3), with high surface gas densities comparable to local dusty starbursts with $\simeq10^{3-5}$$M_{\odot}$/pc$^{2}$. These gas properties suggest that the numerous star-forming clumps are formed through disk instabilities with weak feedback effects. The clumpiness of the Cosmic Grapes significantly exceeds that of galaxies at later epochs and the predictions from current simulations for early galaxies. Our findings shed new light on internal galaxy substructures and their relation to the underlying dynamics and feedback mechanisms at play during their early formation phases, potentially explaining the high abundance of bright galaxies observed in the early Universe and the dark matter core-cusp problem